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The recent cloning of the gene defective in individuals
with Bloom’s syndrome has revealed a link between
DNA helicases, genetic instability and a predisposition
to cancer.
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Several rare human genetic diseases are characterized at
the cellular level by a high incidence of chromosomal
rearrangements. Some of these disorders — in particular,
xeroderma pigmentosum — are associated with abnormal-
ities in the repair of DNA damage, whereas others —
notably Fanconi’s anaemia and Bloom’s syndrome — are
not. Rapid progress has been made in recent years in the
characterisation of the genetic basis for these abnormali-
ties. The recent cloning of the gene, BLM, that is defec-
tive in Bloom’s syndrome has opened the way to a
detailed analysis of the BLM protein and to an under-
standing of the biochemical basis underlying one cause of
genomic instability. 
Bloom’s syndrome individuals exhibit a number of
abnormalities, including pre-natal and post-natal growth
retardation, immunodeficiency and a greatly increased
incidence of cancer. Indeed, of the human syndromes
characterized by genomic instability, Bloom’s syndrome
is associated with the highest incidence of malignant
neoplasms, with the mean age at cancer diagnosis among
affected individuals being only 25 years. Moreover, in
contrast to all other genome instability disorders, Bloom’s
syndrome is associated with an increased incidence of
many different cancers, including both leukaemias and
solid tumours. This suggests that defects in BLM
influence the proper functioning of all cell types in the
body.
A wide body of evidence has accumulated indicating that
the cytogenetic abnormalities displayed by Bloom’s
syndrome cells result from an increased incidence of
chromosomal rearrangements between homologous
sequences. Although these rearrangements take many dif-
ferent forms, a hallmark of the disease is a 10–20-fold
elevation in the frequency of spontaneous sister-
chromatid exchanges (reviewed in [1]). Furthermore, the
high incidence of symmetrical, quadriradial chromosomes
— presumed to be homologous chromosomes caught in
the act of recombination — in Bloom’s syndrome cells is
indicative of an elevated frequency of crossing-over
between homologous chromosomes.
The cloning of the BLM gene is the culmination of many
years’ work on Bloom’s syndrome in the laboratory of
James German [2]. The elegant cloning strategy that
German and colleagues adopted, which exploited the high
incidence of mitotic hyper-recombination events in
Bloom’s syndrome cells, has been reviewed recently [3].
We shall focus on the potential roles of the BLM gene
product, with reference to knowledge that has been
gained from studies on bacterial and lower eukaryotic
homologues of BLM.
The BLM gene is predicted to encode a 159 kDa protein
with a number of identifiable structural motifs (Fig. 1). In
particular, the protein includes seven domains that are
conserved in a variety of ATP-dependent DNA and RNA
helicase enzymes. The BLM protein is most strongly
related to a helicase family of which the prototypical
member is the Escherichia coli RecQ protein [4,5]. This
family also includes the Saccharomyces cerevisiae Sgs1
protein [6,7] and the human RECQL protein (also known
as helicase Q1) [8,9]. Two of these proteins have been
shown to be bona fide DNA helicases, and it is therefore
likely that the BLM protein is also a helicase. Within the
region encompassing the seven helicase domains, the
BLM protein shows 42–44 % sequence identity with
RecQ, Sgs1p and RECQL.
There is, however, considerable structural and sequence
divergence between these proteins outside of the
helicase domains. Most strikingly, BLM and Sgs1p share
a serine rich, highly charged amino-terminal domain of
some 575 amino acids, which is completely absent from
both RecQ and RECQL (Fig. 1). Thus, in structural
terms, it is Sgs1p that most closely resembles BLM,
although their amino-terminal domains show only weak
sequence similarity. Whether this indicates that the
RecQ family of helicases can be separated into two func-
tional sub-groups, based upon the presence or absence of
this extensive amino-terminal domain, remains to be
determined.
The SGS1 gene was isolated by two independent strate-
gies, although both were designed to investigate the func-
tion of topoisomerases. In one case, sgs1 was identified as
a suppressor of the slow-growth phenotype of top3
mutants, which are deficient in topoisomerase III, and
Sgs1p was shown to interact with topoisomerase III in
yeast [6]. Topoisomerase III is a poorly characterized type
I topoisomerase — that is, it acts via the formation of
single-stranded breaks — implicated in suppression of
excessive genetic recombination. In the second strategy,
Sgs1p was identified as a protein that binds topoiso-
merase II using the two-hybrid cloning system [7]. Topoi-
somerase II is an essential enzyme that acts to
disentangle intertwined DNA, and is required for chro-
mosome segregation during cell division (reviewed in
[10]). Topoisomerase II is also necessary for maintenance
of genome stability, particularly in the highly repetitive
ribosomal (r)DNA gene cluster.
Have the analyses of BLM homologues told us anything
about the molecular basis of the defect in Bloom’s syn-
drome cells? The E. coli RecQ protein is a constituent of
the RecF genetic recombination pathway in E. coli [5]. In
a genetic background in which the RecF pathway is opera-
tional, recQ mutations cause a deficiency in conjugational
recombination and hypersensitivity to ultra-violet (UV)
light, consistent with a role for RecQ protein in recombi-
national repair of UV-induced pyrimidine dimers.
Although some similarities exist between recQ and
Bloom’s syndrome mutant cells, it is clear that RecQ
protein is required for efficient genetic recombination and
DNA repair, whereas the phenotype of Bloom’s syndrome
cell lines is one of genetic hyper-recombination coupled
with an apparent proficiency in DNA repair. 
BLM and Sgs1p may be true functional homologues, as
the phenotype of an sgs1D strain includes hyper-recombi-
nation and a high level of genomic instability [6,7], closely
resembling that of a Bloom’s syndrome cell line. The
hyper-recombination in sgs1D strains is manifested as an
increase both in mitotic excision recombination and in
inter-chromosomal homologous recombination ([6] and
our unpublished data). The observed hyper-recombina-
tion is at least partially independent of the RAD52 and
RAD1 genes, suggesting that Sgs1p is not a general com-
ponent of one of the two well-characterized yeast recom-
bination pathways. In sgs1 mutant strains, the rate of
missegregation of chromosomes is increased in both
meiosis and mitosis [7], consistent with Sgs1p having a
cellular role in conjunction with topoisomerases. The
defect in sgs1 mutants primarily causes mitotic and meiotic
chromosome non-disjunction rather than chromosome
loss. By analogy, the observed male infertility and female
subfertility of Bloom’s syndrome patients may result, at
least in part, from meiotic non-disjunction.
Although many pieces of the puzzle remain to be fitted
into place, studies on Bloom’s syndrome cells and yeast
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Figure 1
Schematic representation of the domain structure of BLM and its
homologues. The number of amino acid residues in each protein is
indicated on the right. The amino-terminal and carboxy-terminal
domains found only in Sgs1p and BLM are shown in red and green,
respectively. The blue vertical lines denote the seven helicase
domains, designated from left to right: I, Ia, II, III, IV, V and VI. Domain I
contains the consensus ATP-binding motif; GXGKS/T. The RecQ
family of helicases is characterised by having a DEXH motif in
helicase domain II.
Figure 2
Loss of the BLM helicase may affect
recombination efficiency (1), which can
indirectly influence DNA replication because
of the probable role of the recombination
machinery in ‘repairing’ stalled or damaged
replication forks (2). Alternatively, BLM may be
required directly in replication (3). A failure to
complete recombination or replication could
generate entangled DNA (4) and a
consequent failure during cell division to
disjoin sister chromatids at mitosis or
homologous chromosomes at meiosis.
sgs1 mutants have suggested mechanisms by which a defi-
ciency in helicase function could lead to genomic instabil-
ity (Fig. 2). One possibility is that a recombinogenic
lesion is generated at an increased frequency in sgs1 and
BLM mutant cells, and that this leads to hyper-recombi-
nation and, indirectly, to chromosome non-disjunction.
Alternatively, the helicase may act either directly in repli-
cation or in a recombinational repair process specifically
aimed at restoring replication to regions of the genome
containing stalled or damaged replication forks. In either
case, a failure to complete replication, because of a
sgs1/BLM mutation, would result in non-disjunction
arising through the generation of unresolvable replication
intermediates.
Sgs1p might act at a late stage in DNA replication
alongside its partner topoisomerase II. We have previously
postulated [7] that Sgs1p is involved in unwinding the
small fraction of DNA located at sites of converging repli-
cation forks that cannot be replicated conventionally
because of torsional or steric constraints. Unwinding of
these replication intermediates is a source of the
intertwinings between sister chromatids which must be
resolved by a topoisomerase prior to sister-chromatid
separation at anaphase. The efficiency of this overall
process will thus be a major determinant of the fidelity of
chromosome segregation during cell division.
A lot remains to be clarified regarding the molecular
mechanisms underlying cancer susceptibility in Bloom’s
syndrome and normal individuals. However, it is hoped
that further studies, both in Bloom’s syndrome and yeast
cells, will help to reveal the exact mechanism by which
the BLM family of helicases maintain the integrity of the
eukaryotic genome and consequently suppress cancer.
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